Jefferies Financial Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
3,700
+453
+14% +$209K 0.01% 696
2026
Q1
$1.56M Sell
3,247
-7,466
-70% -$3.82M 0.01% 737
2025
Q4
$6.02M Buy
10,713
+2,481
+30% +$1.41M 0.03% 446
2025
Q3
$4.23M Sell
8,232
-17,021
-67% -$7.43M 0.02% 416
2025
Q2
$7.93M Buy
25,253
+4,218
+20% +$1.27M 0.07% 208
2025
Q1
$6.41M Buy
+21,035
New +$7.08M 0.06% 232
2024
Q4
Sell
-4,270
Closed -$1.43M 1732
2024
Q3
$1.43M Buy
4,270
+1,770
+71% +$672K 0.01% 687
2024
Q2
$1.03M Sell
2,500
-2,318
-48% -$918K 0.01% 738
2024
Q1
$1.95M Buy
+4,818
New +$1.69M 0.02% 605
2023
Q4
Sell
-3,146
Closed -$762K 1878
2023
Q3
$762K Sell
3,146
-70
-2% -$17.9K 0.01% 917
2023
Q2
$772K Buy
+3,216
New +$668K 0.01% 1024

Other funds holding MEDP

Jefferies Financial Group's MEDP Position: Q2 2026 in Review

Jefferies Financial Group increased its Medpace (MEDP) stake by 14% in Q2 2026, buying an estimated $209K and bringing the position to 3,700 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #696.

Jefferies Financial Group first reported a position in MEDP in Q2 2023 and has held it in 11 quarters since. The position peaked at $7.93M in Q2 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Jefferies Financial Group held 3,700 shares of Medpace worth $1.96M as of Q2 2026.
  • Jefferies Financial Group bought 453 Medpace shares in Q2 2026, an estimated $209K.
  • Medpace made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #696 holding.
  • Jefferies Financial Group first reported a position in Medpace in Q2 2023 and has held it in 11 quarters since.
  • Jefferies Financial Group's Medpace position peaked at $7.93M in Q2 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.